Abstract
There is growing evidence that 5-HT3 receptor blockade will benefit patients with fatigue. Further research is needed to determine the mechanism underlying this widespread clinically important symptom and therapies may be derived from targeting the 5-HT system.
Original language | English |
---|---|
Pages (from-to) | 1056-1057 |
Number of pages | 2 |
Journal | Gut |
Volume | 54 |
DOIs | |
Publication status | Published - 1 Aug 2005 |